D.E. Shaw & Co’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

D.E. Shaw & Co’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-95,000	Closed	-$16.4M	–	4046
2015 Q1	$16.4M	Buy	95,000 +75,700	+392%	+$11.1M	0.03%	682
2014 Q4	$2.22M	Sell	19,300 -4,200	-18%	-$509K	﹤0.01%	2194
2014 Q3	$3.67M	Buy	23,500 +10,000	+74%	+$1.45M	﹤0.01%	1777
2014 Q2	$1.67M	Hold	13,500	–	–	﹤0.01%	2461
2014 Q1	$1.4M	Buy	13,500 +8,500	+170%	+$870K	﹤0.01%	2734
2013 Q4	$450K	Buy	+5,000	New	+$399K	﹤0.01%	3790

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's SLXP Position: Q2 2015 in Review

D.E. Shaw & Co sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 258,455 shares — an estimated $44.7M sold.

D.E. Shaw & Co first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $44.7M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

D.E. Shaw & Co reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
D.E. Shaw & Co sold 258,455 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $44.7M.
D.E. Shaw & Co first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
D.E. Shaw & Co's SALIX PHARMACEUTICALS LTD DEL position peaked at $44.7M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.